Reviva Pharmaceuticals Hldg Inc (RVPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,190 | 14,439 | 13,183 | 10,364 | 5,289 |
| TOTAL | $23,560 | $15,104 | $13,513 | $10,815 | $6,257 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 820 | 820 | 820 | 820 |
| TOTAL | $N/A | $820 | $820 | $820 | $820 |
| Total Assets | $23,560 | $15,923 | $14,333 | $11,635 | $7,077 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,085 | 3,009 | 5,432 | 4,969 | 4,721 |
| Accrued Expenses | 3,084 | 3,068 | 3,676 | 6,073 | 6,081 |
| TOTAL | $6,119 | $7,276 | $9,738 | $12,077 | $11,509 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 45 | 17 | 28 |
| TOTAL | $N/A | $N/A | $45 | $17 | $28 |
| Total Liabilities | $6,119 | $7,276 | $9,783 | $12,094 | $11,537 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,110 | 12,810 | 5,753 | 3,400 | 2,337 |
| Common Shares | 12 | 12 | 10 | 7 | 5 |
| Retained earnings | -187,334 | -184,138 | -180,770 | -176,760 | -170,706 |
| TOTAL | $17,441 | $8,648 | $4,550 | $-459 | $-4,460 |
| Total Liabilities And Equity | $23,560 | $15,923 | $14,333 | $11,635 | $7,077 |